How M.D. was paid
$3.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Allan Reine, M.D.Chief Executive Officer | $606,212 | $2,828,798 | $402,000 | $57,177 | $3,894,187 |
| Keith Gottesdiener, M.D.Former Chief Executive Officer | $259,568 | $1,185,802 | — | $762,400 | $2,207,770 |
| Ann Lee, Ph.D.Chief Technical Officer | $505,375 | $790,075 | $243,960 | $10,706 | $1,550,116 |
| Jeremy Duffield, M.D., Ph.D., FRCPFormer Chief Scientific Officer | $268,271 | $668,600 | — | $380,926 | $1,317,797 |
What changed and why
- $3.9MAllan Reine total compensation for 2025 was $3,894,187 after becoming Chief Executive Officer in May.
- Keith Gottesdiener stepped down as Chief Executive Officer in May 2025 and received severance payments.
- 120%Ann Lee earned an annual cash bonus payout equal to 120% of target based on corporate achievement.
- Equity awards granted to executives included both time-based and performance-based stock options.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.